Advances in normothermic perfusion of the liver
Peter J. Friend – 17 August 2017
Charting the transcriptional regulatory changes in mouse liver during fasting
Elodie Thierion, Duncan T. Odom – 17 August 2017
Reconstruction of anomalous portal venous branching in right lobe living donor liver transplantation: Malatya approach
Chetan Ramesh Kalal, Hunaid Hatimi, Ravi Mohanka – 17 August 2017
Longterm outcome of the liver graft: The pathologist's perspective
Anthony J. Demetris – 17 August 2017
Influence of outflow‐obstructed liver volume and venous communication development: A three‐dimensional volume study in living donors
Yoshikuni Kawaguchi, Kiyoshi Hasegawa, Naoki Okura, Harufumi Maki, Nobuhisa Akamatsu, Junichi Kaneko, Junichi Arita, Yoshihiro Sakamoto, Kuni Ohtomo, Norihiro Kokudo – 17 August 2017 – Living donor liver transplantation using the left liver graft with the middle hepatic vein (MHV) is a well‐established procedure. Following such procedures, outflow obstruction occurs in remnant livers. However, the effects of the outflow‐obstructed liver volume (LVOut‐Ob), with or without venous communication development, remain unclear.
Liver transplant in patients with portal vein thrombosis: Medical and surgical requirements
Kendra D. Conzen, Elizabeth A. Pomfret – 17 August 2017
Increased myocardial contractility identifies patients with decompensated cirrhosis requiring liver transplantation
Christian Jansen, Alexander Cox, Robert Schueler, Matthias Schneider, Jennifer Lehmann, Michael Praktiknjo, Alessandra Pohlmann, Johannes Chang, Steffen Manekeller, Georg Nickenig, Gabriela Berlakovich, Christian P. Strassburg, Christoph Hammerstingl, Katharina Staufer, Jonel Trebicka – 17 August 2017 – Late allocation of organs for transplant impairs post–liver transplantation (LT) survival. Cardiac dysfunction, especially diastolic and autonomic dysfunction, is frequent and plays an important role in the prognosis of patients with cirrhosis.
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman, Vlad Ratziu, Stephen A. Harrison, Manal F. Abdelmalek, Guruprasad P. Aithal, Juan Caballeria, Sven Francque, Geoffrey Farrell, Kris V. Kowdley, Antonio Craxi, Krzysztof Simon, Laurent Fischer, Liza Melchor‐Khan, Jeffrey Vest, Brian L.
Projected increase in obesity and non‐alcoholic‐steatohepatitis–related liver transplantation waitlist additions in the United States
Neehar D. Parikh, Wesley J. Marrero, Jingyuan Wang, Justin Steuer, Elliot B. Tapper, Monica Konerman, Amit G. Singal, David W. Hutton, Eunshin Byon, Mariel S. Lavieri – 17 August 2017 – Nonalcoholic steatohepatitis (NASH) cirrhosis is the fastest growing indication for liver transplantation (LT) in the United States. We aimed to determine the temporal trend behind the rise in obesity and NASH‐related additions to the LT waitlist in the United States and make projections for future NASH burden on the LT waitlist.
MicroRNA‐337‐3p controls hepatobiliary gene expression and transcriptional dynamics during hepatic cell differentiation
Céline Demarez, Claude Gérard, Sabine Cordi, Alexis Poncy, Younes Achouri, Nicolas Dauguet, David A. Rosa, Patrick T. Gunning, Isabelle Manfroid, Frédéric P. Lemaigre – 17 August 2017 – Transcriptional networks control the differentiation of the hepatocyte and cholangiocyte lineages from embryonic liver progenitor cells and their subsequent maturation to the adult phenotype. However, how relative levels of hepatocyte and cholangiocyte gene expression are determined during differentiation remains poorly understood. Here, we identify microRNA (miR)‐337‐3p as a regulator of liver development.